Denka Seiken to Start Development of Mass Production Technology for Therapeutic Oncolytic Virus for Cancer Therapy

May 13, 2015
Denka Kagaku Kogyo and its subsidiary Denka Seiken said on May 12 that Denka Seiken will initiate the development of mass production technology for the production of oncolytic virus agent G47Δ (delta) on contract from Prof. Tomoki Todo of the...read more